PDF(Pubmed)
Abstract：
Information on the state of the environment is important to achieve the objectives of the European Green Deal, including the EU\'s Biodiversity Strategy for 2030. The existing regulatory provisions for genetically modified organisms (GMOs) foresee an obligatory post-market environmental monitoring (PMEM) of potential adverse effects upon release into the environment. So far, GMO monitoring activities have focused on genetically modified crops. With the advent of new genomic techniques (NGT), novel GMO applications are being developed and may be released into a range of different, non-agricultural environments with potential implications for ecosystems and biodiversity. This challenges the current monitoring concepts and requires adaptation of existing monitoring programs to meet monitoring requirements. While the incorporation of existing biodiversity monitoring programs into GMO monitoring at the national level is important, additional monitoring activities will also be required. Using case examples, we highlight that monitoring requirements for novel GMO applications differ from those of GM crop plants previously authorized for commercial use in the European Union.
摘要：
有关环境状况的信息对于实现欧洲绿色协议的目标很重要，包括欧盟2030年生物多样性战略。现有的转基因生物（GMOs）法规规定必须对释放到环境中的潜在不利影响进行强制性的上市后环境监测（PMEM）。到目前为止,转基因生物监测活动集中在转基因作物上。随着新基因组技术（NGT）的出现，新的GMO应用程序正在开发中，可能会发布到一系列不同的对生态系统和生物多样性有潜在影响的非农业环境。这对当前的监控概念提出了挑战，并要求对现有监控程序进行调整以满足监控要求。虽然将现有的生物多样性监测计划纳入国家一级的转基因生物监测很重要，还需要额外的监测活动。使用案例示例，我们强调，新型转基因生物应用的监测要求与欧盟先前授权商业使用的转基因作物植物的监测要求不同。
